Determination the effectiveness of Carbamazepine alone with the combined use of Carbamazepine and Lacosamide in patients with uncontrolled epilepsy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231128060214N1

Enrollment

100

Registered

2025-02-22

Start date

2024-03-20

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy. Epilepsy and recurrent seizures

Interventions

Intervention 1: Intervention group: combined use of carbamazepin and lacosamide. Intervention 2: Control group: use of carbamazepine alone.

Eligibility

Sex/Gender

All

Age

16 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with grand mal or complex partial epilepsy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Reduction of seizure frequency in 6 months after simultaneous use of two drugs. Timepoint: 6 month later. Method of measurement: Questions from patients.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNiloofar abdi

Hamedan University of Medical Sciences

niloofarabdi9957@gmail.com+98 81 3264 0043

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026